Monday, June 15

Browsing: NonCNS

Support

FDA Approves Gadoquatrane to Detect CNS and Non-CNS Body Region Lesions

By NewsCancerJune 15, 20260

The FDA has approved gadoquatrane (Ambelvist) for contrast-enhanced MRI to detect and visualize lesions with abnormal vascularity in the central…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.